Profiel
Guikai George Wu is the founder of Amberstone Biosciences, Inc. He currently holds the titles of President, CEO, and Chief Financial Officer at the company.
The company was founded in 2018.
Actieve functies van Guikai George Wu
| Bedrijven | Functie | Begin |
|---|---|---|
Amberstone Biosciences, Inc.
 Amberstone Biosciences, Inc. BiotechnologyHealth Technology Amberstone Biosciences, Inc. is a company that aims to eliminate the issues of dose toxicity interfering with drug efficacy by introducing a safer class of therapeutic agents. The company is based in Laguna Hills, CA. The company's team of scientists and engineers strives to discover and develop transformative immunotherapeutics, pioneering a new wave of therapeutic breakthroughs. The company is developing first-in-class tumor microenvironment activated therapeutic (T-MATE). The company was founded in 2018 by Guikai George Wu. Guikai George Wu has been the CEO since 2018. | Algemeen Directeur | 01-01-2018 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Amberstone Biosciences, Inc.
Amberstone Biosciences, Inc. BiotechnologyHealth Technology Amberstone Biosciences, Inc. is a company that aims to eliminate the issues of dose toxicity interfering with drug efficacy by introducing a safer class of therapeutic agents. The company is based in Laguna Hills, CA. The company's team of scientists and engineers strives to discover and develop transformative immunotherapeutics, pioneering a new wave of therapeutic breakthroughs. The company is developing first-in-class tumor microenvironment activated therapeutic (T-MATE). The company was founded in 2018 by Guikai George Wu. Guikai George Wu has been the CEO since 2018. | Health Technology |
